Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis

Diabetologia

Volumn 59, Issue 5, 2016, Pages 933-937

  Perry, Rachel J ^a   Petersen, Kitt Falk ^a,b   Shulman, Gerald I ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Capital Region   (Denmark)

Author keywords

Diabetic ketoacidosis; Leptin; Lipodystrophy; Review; Type 1 diabetes

Indexed keywords

INSULIN; LEPTIN;

DIABETIC KETOACIDOSIS; GLUCONEOGENESIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; KETOACIDOSIS; LIPODYSTROPHY; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; ANIMAL; DIABETES MELLITUS, TYPE 1; METABOLISM;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HUMANS; INSULIN RESISTANCE; LEPTIN;

EID: 84960324641     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3909-4     Document Type: Review

References (23)

1. Petersen KF, Oral EA, Dufour S et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350
2. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176
3. Shulman GI (2014) Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371:1131–1141
4. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456–8460
5. Fujikawa T, Berglund ED, Patel VR et al (2013) Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab 18:431–444
6. Meek TH, Matsen ME, Dorfman MD et al (2013) Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia. Endocrinology 154:3067–3076
7. Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R (2010) Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci U S A 107:17391–17396
8. Chinookoswong N, Wang JL, Shi ZQ (1999) Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48:1487–1492
9. Wang MY, Chen L, Clark GO et al (2010) Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A 107:4813–4819
10. Yu X, Park BH, Wang MY, Wang ZV, Unger RH (2008) Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A 105:14070–14075
11. Chen L, Philippe J, Unger RH (2011) Glucagon responses of isolated alpha cells to glucose, insulin, somatostatin, and leptin. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists 17:819–825
12. Kim GH, Szabo A, King EM, Ayala J, Ayala JE, Altarejos JY (2015) Leptin recruits Creb-regulated transcriptional coactivator 1 to improve hyperglycemia in insulin-deficient diabetes. Mol Metab 4:227–236
13. Meek TH, Matsen ME, Damian V, Cubelo A, Chua SC Jr, Morton GJ (2014) Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes. Endocrinology 155:4157–4167
14. Perry RJ, Lee S, Ma L, Zhang D, Schlessinger J, Shulman GI (2015) FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis. Nat Commun 6:6980
15. Perry RJ, Zhang XM, Zhang D et al (2014) Leptin reverses diabetes by suppression of the hypothalamic–pituitary–adrenal axis. Nat Med 20:759–763
16. Minokoshi Y, Toda C, Okamoto S (2012) Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian J Endocrinol Metab 16:S562–S568
17. Toda C, Shiuchi T, Kageyama H et al (2013) Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle. Diabetes 62:2295–2307
18. Laker RC, Henry BA, Wadley GD, Clarke IJ, Canny BJ, McConell GK (2011) Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep. Am J Physiol Regul Integr Comp Physiol 300:R511–R518
19. Oral EA, Simha V, Ruiz E et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570–578
20. Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103
21. Morton GJ, Meek TH, Matsen ME, Schwartz MW (2015) Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin. J Clin Invest 125:4587–4591
22. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA (1987) Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510–1515
23. Perry RJ, Camporez JP, Kursawe R et al (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160:745–758